http://chineseinput.net/에서 pinyin(병음)방식으로 중국어를 변환할 수 있습니다.
변환된 중국어를 복사하여 사용하시면 됩니다.
The Advantage of an Endoscopic Submucosal Tunneling Technique for Rectal Carcinoid Tumors
( Hideki Kobara ),( Hirohito Mori ),( Li Chei Shintaro Fujihara ),( Noriko Nishiyama ),( Tsutomu Masaki ) 대한간학회 2017 Gut and Liver Vol.11 No.5
Endoscopic treatment can be a curative option for small carcinoid tumors with an extremely low risk of metastasis. Since most carcinoid tumors are characterized by a specific growth pattern in the submucosal (SM) layer, specialized endoscopic techniques for deeper resection to achieve clear vertical margins are needed. The endoscopic submucosal dissection (ESD) method in the SM space is superior to con-ventional endoscopic mucosal resection. However, the stan-dard ESD technique sometimes fails to provide complete deep SM dissection due to insufficient SM lifting. Here, to resolve this problem, we describe our initial experience with an endoscopic SM tunneling technique that is effective for treating rectal carcinoid tumors. (Gut Liver 2017;11:735- 737)
Makoto Fujimoto,Koichi Tsuneyama,Yuko Nakanishi,Thucydides L. Salunga,Kazuhiro Nomoto,Yoshiyuki Sasaki,Seiichi Iizuka,Mitsunobu Nagata,Wataru Suzuki,Tsutomu Shimada,Masaki Aburada,Yutaka Shimada,M. Er 한국식품영양과학회 2014 Journal of medicinal food Vol.17 No.3
The metabolic syndrome is a major worldwide health care issue and a dominant risk factor for cardiovascular disease. The liver manifestations of this syndrome include nonalcoholic fatty liver disease (NAFLD) and its progressive variant nonalcoholic steatohepatitis (NASH). Although significant research has been performed, the basic pathogenesis of NAFLD/NASH remains controversial and effective treatments are still unavailable. We have previously reported on a murine model of NASH induced by the neonatal injection of monosodium glutamate (MSG), which includes the clinical manifestations of central obesity, diabetes, hyperlipidemia, and ultimately liver inflammation, fibrosis, and cancer. Although MSG is considered a safe food additive, its administration to pregnant rats increases the voracity and growth hormone levels in the offspring. To further understand the biology of this model, we have investigated the influence of the calorie intake on these clinical manifestations by feeding animals a restrictive diet. MSG-treated animals fed a restrictive diet continue to manifest obesity and early stage NASH but have improvements in serum lipid profiles. At 12 months of age, mice had manifestations of obesity, whether animals were fed a restricted or control diet, but animals fed a restrictive diet had a reduction in the progression of NASH. In conclusion, MSG appears to be a critical factor in the initiation of obesity, whereas calorie intake may modulate the progression of disease.